2 Mega-Dividend Stocks With Yields As High As 7%

Source The Motley Fool

Key Points

  • Investors can evaluate a company's dividend by looking at its track record, earnings, and free cash flow.

  • While not super common, there are safe high-yielding dividends to be found.

  • These companies have gained the trust of the market when it comes to their dividends.

  • 10 stocks we like better than Pfizer ›

Investing in dividend stocks can be a great way to generate passive income in a more reliable manner than investing in stocks for pure appreciation. The key is to find stocks with good dividend track records that can generate enough earnings and free cash flow to continue paying the current dividend and raise it in the future.

While stocks with high dividend yields can generate skepticism from the market, there are a number that are trustworthy. Here are two mega-dividend stocks with yields as high as 7%.

Where to invest $1,000 right now? Our analyst team just revealed what they believe are the 10 best stocks to buy right now. Continue »

Person holding fan of cash.

Image source: Getty Images.

Pfizer: Continuing to build a solid drug pipeline and navigate tariffs

The large U.S. drugmaker Pfizer (NYSE: PFE) played a key role in administering COVID-19 vaccines that helped ease the economy out of the pandemic. But following this monumental effort, investors questioned what the company's next hit would be.

In 2023, Pfizer announced the $43 billion acquisition of Seagen to significantly bolster its oncology pipeline. Management's big pitch to investors for the acquisition is that Seagen's pipeline could contribute $10 billion in adjusted revenue by 2030. Along with other acquisitions, the company expects to lift revenue by over $20 billion by 2030. However, the purpose of this is to counteract a projected $17 billion in lost revenue between this year and 2030, as patents on certain drugs that grant Pfizer exclusivity expire.

Pfizer has also been beefing up on weight-loss drugs. It recently announced the acquisition of Metsera in a deal that could be worth up to $7.3 billion. Wall Street analyst David Risinger, who works for Leerink, estimates that Metsera's pipeline could eventually yield over $5 billion of revenue. Pfizer has also been navigating the ongoing tariff saga. Recently, the Trump administration granted Pfizer a three-year exemption from pharma-specific tariffs. In return, Pfizer will invest an additional $70 billion into U.S. manufacturing and research.

Pfizer has a solid dividend track record, having now paid and raised its dividend for 16 straight years. The yield is also quite impressive at over 7%. Management remains committed to the dividend, and is focusing on growing revenue and prudently managing expenses to drive growth in the company's operating margins. With a trailing 12-month free cash flow yield approaching 9%, the company is still safely covering its dividend.

Verizon: A strategic revamp and steady dividend

The large telecommunications company Verizon (NYSE: VZ) has signaled that change is coming. It recently announced that Dan Schulman, a member of the board of directors and the former CEO of PayPal, will become the new CEO of Verizon, replacing Hans Vestberg.

For years, Verizon has been working to increase its subscriber base by expanding its fiber-optic network in order to offer its customers superior service. It's also been increasing subscription numbers for its fixed wireless access product, which is wireless service for those living in areas without access to fiber-optic cables.

But the results have not been well received by the market, according to New Street analyst David Barden. He noted that Verizon has added 5 million organic postpaid phones, while the industry has added roughly 55 million since Vestberg took the job.

"When Hans joined, Verizon was capturing over 20% of annual industry postpaid phone net adds; that share has fallen to an average of 5% over the last four years," Barden wrote in his research note, according to Barrons. Verizon's stock has fallen roughly 30% over the past five years.

Citing anonymous sources, The Wall Street Journal reported that Schulman will now focus on getting more from Verizon's assets and increasing customer satisfaction.

Despite changes to Verizon's strategy, the dividend still looks good. The company has now paid and increased its dividend for 19 straight years, and offers a great yield of 6.8%, partly due to how the stock has struggled in recent years. With a 12-month trailing free cash flow yield of nearly 11.5%, the dividend is well supported.

Should you invest $1,000 in Pfizer right now?

Before you buy stock in Pfizer, consider this:

The Motley Fool Stock Advisor analyst team just identified what they believe are the 10 best stocks for investors to buy now… and Pfizer wasn’t one of them. The 10 stocks that made the cut could produce monster returns in the coming years.

Consider when Netflix made this list on December 17, 2004... if you invested $1,000 at the time of our recommendation, you’d have $646,805!* Or when Nvidia made this list on April 15, 2005... if you invested $1,000 at the time of our recommendation, you’d have $1,123,113!*

Now, it’s worth noting Stock Advisor’s total average return is 1,055% — a market-crushing outperformance compared to 189% for the S&P 500. Don’t miss out on the latest top 10 list, available when you join Stock Advisor.

See the 10 stocks »

*Stock Advisor returns as of October 20, 2025

Bram Berkowitz has no position in any of the stocks mentioned. The Motley Fool has positions in and recommends PayPal and Pfizer. The Motley Fool recommends Verizon Communications and recommends the following options: long January 2027 $42.50 calls on PayPal and short December 2025 $75 calls on PayPal. The Motley Fool has a disclosure policy.

Disclaimer: For information purposes only. Past performance is not indicative of future results.
placeholder
Bitcoin ETF Inflows For 2025 Now Outpace 2024, Data ShowsUS Bitcoin spot exchange-traded funds (ETFs) have seen more inflows this year so far compared to the same point in 2024, according to data.
Author  Bitcoinist
Jul 16, Wed
US Bitcoin spot exchange-traded funds (ETFs) have seen more inflows this year so far compared to the same point in 2024, according to data.
placeholder
What to expect from Ethereum in October 2025With broader sentiment worsening, user demand falling across the Ethereum network, and institutional investors pulling back, the coin faces mounting headwinds in October.
Author  Beincrypto
Sep 30, Tue
With broader sentiment worsening, user demand falling across the Ethereum network, and institutional investors pulling back, the coin faces mounting headwinds in October.
placeholder
Silver Price Forecast: XAG/USD stabilizes above $52 after healthy correctionSilver price (XAG/USD) trades 0.7% higher to near $52.30 during the late Asian trading session on Monday.
Author  FXStreet
Yesterday 05: 50
Silver price (XAG/USD) trades 0.7% higher to near $52.30 during the late Asian trading session on Monday.
placeholder
Solana Price Forecast: SOL extends recovery as trading volume surgesSolana (SOL) price extends its recovery, trading above $192 at the time of writing on Monday, after rebounding from the ascending trendline support last week.
Author  FXStreet
Yesterday 07: 30
Solana (SOL) price extends its recovery, trading above $192 at the time of writing on Monday, after rebounding from the ascending trendline support last week.
placeholder
Why the Altcoin Market Cap Decline May Deepen in OctoberThe crypto market has been turbulent in October, with altcoin market capitalization dropping another 15%. Could this downturn worsen before October ends?
Author  Beincrypto
Yesterday 10: 03
The crypto market has been turbulent in October, with altcoin market capitalization dropping another 15%. Could this downturn worsen before October ends?
goTop
quote